Cytodyn Inc (CYDY)

[HyGro]

BP has no interest in Leronlimab -- they've had decades to buy it for pocket change and NONE have even made an offer. Only Vyera, the worst pharma in the U.S. gave the company ANY money for a partnership (only $5 million) and they are taking 50% of the HIV revenue. Progenics could get now takers after Phase 2 trials were successful, they actually shelved if for years until Cytodyn paid a measly $3.5 million to buy the rights. Since then -- nothing from BP. No BP has bought or partnered with an OTC penny stock biotech drug company over the last decade. Why would a BP get tied up in the nightmare of an OTC that is insolvent, under SEC and DOJ investigation, under shareholder class action lawsuit and has pissed off the FDA. It is a train wreck that no other company would want to get entangled in.